In last trading session, Caredx Inc (NASDAQ:CDNA) saw 0.88 million shares changing hands with its beta currently measuring 2.17. Company’s recent per share price level of $18.90 trading at $1.26 or 7.14% at ring of the bell on the day assigns it a market valuation of $1.05B. That closing price of CDNA’s stock is at a discount of -84.34% from its 52-week high price of $34.84 and is indicating a premium of 60.74% from its 52-week low price of $7.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.9 million shares which gives us an average trading volume of 879.56K if we extend that period to 3-months.

For Caredx Inc (CDNA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.89. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.07 in the current quarter.

Caredx Inc (NASDAQ:CDNA) trade information

Upright in the green during last session for gaining 7.14%, in the last five days CDNA remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $18.90 price level, adding 0.68% to its value on the day. Caredx Inc’s shares saw a change of -11.72% in year-to-date performance and have moved -0.11% in past 5-day. Caredx Inc (NASDAQ:CDNA) showed a performance of -21.12% in past 30-days. Number of shares sold short was 5.18 million shares which calculate 5.5 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 30 to the stock, which implies a rise of 37.0% to its current value. Analysts have been projecting 25 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -32.28% in reaching the projected high whereas dropping to the targeted low would mean a loss of -32.28% for stock’s current value.

Caredx Inc (CDNA) estimates and forecasts

This year revenue growth is estimated to rise 11.10% from the last financial year’s standing.

8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 84.56M for the same. And 8 analysts are in estimates of company making revenue of 90.69M in the next quarter. Company posted 72.05M and 92.27M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around -148.39% while estimates for its earnings growth in next 5 years are of -19.23%.

Caredx Inc (NASDAQ:CDNA)’s Major holders

Insiders are in possession of 3.37% of company’s total shares while institution are holding 94.89 percent of that, with stock having share float percentage of 98.20%. Investors also watch the number of corporate investors in a company very closely, which is 94.89% institutions for Caredx Inc that are currently holding shares of the company. ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at CDNA for having 5.7 million shares of worth $88.56 million. And as of 2024-06-30, it was holding 10.925 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 5.29 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.1283 of outstanding shares, having a total worth of $82.1 million.

On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF and Baron Discovery Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.38 shares of worth $44.9 million or 4.29% of the total outstanding shares. The later fund manager was in possession of 1.68 shares on Dec 31, 2024 , making its stake of worth around $31.78 million in the company or a holder of 3.03% of company’s stock.